82 related articles for article (PubMed ID: 8523115)
1. Technetium-99m-tetrofosmin imaging of differentiated mixed thyroid cancer.
Klain M; Maurea S; Lastoria S; Cuocolo A; Colao A; Lombardi G; Salvatore M
J Nucl Med; 1995 Dec; 36(12):2248-51. PubMed ID: 8523115
[TBL] [Abstract][Full Text] [Related]
2. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma.
Lind P; Gallowitsch HJ; Langsteger W; Kresnik E; Mikosch P; Gomez I
J Nucl Med; 1997 Mar; 38(3):348-52. PubMed ID: 9074515
[TBL] [Abstract][Full Text] [Related]
3. Technetium-99m tetrofosmin imaging in thyroid diseases: comparison with Tc-99m-pertechnetate, thallium-201 and Tc-99m-methoxyisobutylisonitrile scans.
Klain M; Maurea S; Cuocolo A; Colao A; Marzano L; Lombardi G; Salvatore M
Eur J Nucl Med; 1996 Dec; 23(12):1568-74. PubMed ID: 8929309
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m tetrofosmin and technetium-99m sestamibi imaging of multiple metastases from differentiated thyroid carcinoma.
Kosuda S; Yokoyama H; Katayama M; Yokokawa T; Kusano S; Yamamoto O
Eur J Nucl Med; 1995 Oct; 22(10):1218-20. PubMed ID: 8542909
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of thyroid nodules with technetium-99m tetrofosmin dual-phase scintigraphy.
Kresnik E; Gallowitsch HJ; Mikosch P; Molnar M; Pipam W; Gomez I; Lind P
Eur J Nucl Med; 1997 Jul; 24(7):716-21. PubMed ID: 9211755
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m tetrofosmin uptake in insular thyroid carcinoma. A comparison with iodine-131.
Degirmenci B; Aydin A; Comlekci A; Ozdogan O; Bekis R
Clin Nucl Med; 2003 May; 28(5):385-8. PubMed ID: 12702934
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m-tetrofosmin scintigraphy in pulmonary tuberculosis.
Degirmenci B; Kilinc O; Cirak KA; Capa G; Akpinar O; Halilcolar H; Durak H; Akkoclu A; Derebek E; Ucan ES
J Nucl Med; 1998 Dec; 39(12):2116-20. PubMed ID: 9867153
[TBL] [Abstract][Full Text] [Related]
8. Positive thyroid cancer scintigraphy using 99Tcm-tetrofosmin (Myoview): a preliminary report.
Nĕmec J; Nývltová O; Preiningerová M; Vlcek P; Racek P; Novák Z; Blazek T; Zimák J
Nucl Med Commun; 1995 Aug; 16(8):694-7. PubMed ID: 7491183
[TBL] [Abstract][Full Text] [Related]
9. [99mTc Tetrofosmin in diagnosis of distant metastases from differentiated thyroid cancer].
Drac-Kaniewska J; Kozłowicz-Gudzińska I; Tomaszewicz-Kubasik H; Kaniewski M; Godlewska P; Czetwertyńska M; Chaładaj-Kujawska A
Wiad Lek; 2001; 54 Suppl 1():357-62. PubMed ID: 12182048
[TBL] [Abstract][Full Text] [Related]
10. Recurrent follicular carcinoma-oxyphilic cell type (Hürthle cell carcinoma) of the thyroid, imaging with iodine-131 and technetium-99m tetrofosmin before and after radiotherapy.
Bomanji JB; Gacinovic S; Gaze MN; Costa DC; Ell PJ
Br J Radiol; 1998 Jan; 71(841):87-9. PubMed ID: 9534706
[TBL] [Abstract][Full Text] [Related]
11. [Two cases of breast cancer detected by 99mTc-tetrofosmin myocardial scintigraphy].
Adachi I; Tabuchi K; Yamamoto K; Nakata Y; Nanba R; Nishigaki H; Matsui R; Sueyoshi K; Narabayahi I; Ohkubo T; Tamoto S; Ohtake Y
Kaku Igaku; 1996 May; 33(5):531-6. PubMed ID: 8699621
[TBL] [Abstract][Full Text] [Related]
12. Value of (99m)Tc tetrofosmin scan in well-differentiated thyroid cancer.
Gallegos-Hernández JF; Pichardo-Romero P; Esparza-Pérez H; Reséndiz-Colosia JA; Minauro-Muñoz GG; Hernández-Hernández DM
Cir Cir; 2009; 77(4):275-8; 257-9. PubMed ID: 19919788
[TBL] [Abstract][Full Text] [Related]
13. Relation between (99m)Tc-tetrofosmin thyroid scintigraphy and mitogen-activated protein kinase in papillary thyroid cancer patients.
Baba K; Ishibashi M; Kaida H; Fujii T; Hiromatsu Y; Kawahara A; Kage M; Hayabuchi N
Jpn J Radiol; 2011 Oct; 29(8):533-9. PubMed ID: 21927994
[TBL] [Abstract][Full Text] [Related]
14. Technetium-99m-pentavalent dimercaptosuccinic acid uptake in Hurthle cell tumor of the thyroid.
Vergara E; Lastoria S; Varrella P; Lapenta L; Salvatore M
J Nucl Biol Med (1991); 1993 Jun; 37(2):65-8. PubMed ID: 8396979
[TBL] [Abstract][Full Text] [Related]
15. 99mTc-MIBI in differentiated thyroid carcinoma.
Roelants V; Beckers C
J Nucl Med; 1999 Oct; 40(10):1769. PubMed ID: 10520721
[No Abstract] [Full Text] [Related]
16. Technetium-99m tetrofosmin imaging in patients with subacute thyroiditis.
Hiromatsu Y; Ishibashi M; Miyake I; Nonaka K
Eur J Nucl Med; 1998 Oct; 25(10):1448-52. PubMed ID: 9818287
[TBL] [Abstract][Full Text] [Related]
17. Technetium-99m-tetrofosmin uptake in sarcoidosis stage I.
Tschabitscher D; Gallowitsch HJ; Mikosch P; Kresnik E; Gomez I; Molnar M; Dinges HP; Kroiss A; Lind P
J Nucl Med; 1997 Nov; 38(11):1786-7. PubMed ID: 9374356
[TBL] [Abstract][Full Text] [Related]
18. 99mTc-tetrofosmin uptake in bone metastases from breast cancer.
Takayama T; Kinuya S; Sugiyama M; Hashiba A; Takeda R; Onoguchi M; Tsuji S; Tonami N
Ann Nucl Med; 1998 Oct; 12(5):293-6. PubMed ID: 9839492
[TBL] [Abstract][Full Text] [Related]
19. Metastatic medullary thyroid cancer: localization with iodine-131 metaiodobenzylguanidine.
Sone T; Fukunaga M; Otsuka N; Morita R; Muranaka A; Yanagimoto S; Tomomitsu T; Nakayama H; Harada T
J Nucl Med; 1985 Jun; 26(6):604-8. PubMed ID: 3158726
[TBL] [Abstract][Full Text] [Related]
20. Breast cyst simulating metastases on iodine-131 imaging in thyroid carcinoma.
Serafini A; Sfakianakis G; Georgiou M; Morris J
J Nucl Med; 1998 Nov; 39(11):1910-2. PubMed ID: 9829582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
